| Database ID | Agent | Target | Cancer Type | Detail |
| DB00031 | panitumumab | Epidermal growth factor receptor | colorectal cancer | view |
| DB00032 | panitumumab | Epidermal growth factor receptor | colorectal cancer | view |
| DB00033 | panitumumab | Epidermal growth factor receptor | colorectal cancer | view |
| DB00034 | panitumumab | Epidermal growth factor receptor | colorectal cancer | view |
| DB00035 | panitumumab | Epidermal growth factor receptor | colorectal cancer | view |
| DB00036 | panitumumab | Epidermal growth factor receptor | colorectal cancer | view |
| DB00037 | bevacizumab | Vascular endothelial growth factor
Epidermal growth factor receptor | colorectal cancer | view |
| DB00038 | aflibercept | VEGFA, vascular endothelial growth factor B, PIGF | ovarian cancer | view |
| DB00039 | aflibercept | VEGFA, vascular endothelial growth factor B, PIGF | advanced solid tumors | view |
| DB00040 | aflibercept | VEGFA, vascular endothelial growth factor B, PIGF | prostate cancer | view |
| DB00041 | bevacizumab | Vascular endothelial growth factor
Epidermal growth factor receptor | prostate cancer | view |
| DB00042 | bevacizumab | Vascular endothelial growth factor
Epidermal growth factor receptor | prostate cancer | view |
| DB00043 | dasatinib | Protooncogene tyrosineprotein kinase SRC
Abl
Protooncogene tyrosineprotein kinase LCK
Protooncogene tyrosineprotein kinase Fyn | prostate cancer | view |
| DB00044 | dasatinib | Protooncogene tyrosineprotein kinase SRC
Abl
Protooncogene tyrosineprotein kinase LCK
Protooncogene tyrosineprotein kinase Fyn | prostate cancer | view |
| DB00045 | dasatinib | Protooncogene tyrosineprotein kinase SRC
Abl
Protooncogene tyrosineprotein kinase LCK
Protooncogene tyrosineprotein kinase Fyn | prostate cancer | view |